Clinical Trial Update: Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating pianzumab in combination with the AVD chemotherapy regimen for newly diagnosed advanced classical Hodgkin lymphoma and is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Doxorubicin (doxorubicin)
• Pianzumab (pianzumab)
• Vinblastine (vinblastine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Classic Hodgkin Lymphoma | Phase 2 | Status: RECRUITING